RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+4.23%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$5.08B
AUM Growth
+$5.08B
Cap. Flow
+$263M
Cap. Flow %
5.19%
Top 10 Hldgs %
55.13%
Holding
68
New
14
Increased
10
Reduced
3
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
HOWL icon
51
Werewolf Therapeutics
HOWL
$62.6M
$13.2M 0.26%
6,144,881
CELC icon
52
Celcuity
CELC
$2.3B
$12.8M 0.25%
1,400,001
NKTR icon
53
Nektar Therapeutics
NKTR
$543M
$11.1M 0.22%
+1,246,667
New +$11.1M
NKTX icon
54
Nkarta
NKTX
$149M
$10.8M 0.21%
7,805,129
BDTX icon
55
Black Diamond Therapeutics
BDTX
$164M
$10.1M 0.2%
3,525,754
CMPS
56
Compass Pathways
CMPS
$452M
$9.52M 0.19%
+1,286,000
New +$9.52M
SLDB icon
57
Solid Biosciences
SLDB
$448M
$8.63M 0.17%
3,426,286
IGMS
58
DELISTED
IGM Biosciences
IGMS
$7.83M 0.15%
937,500
TRML icon
59
Tourmaline Bio
TRML
$645M
$6.75M 0.13%
240,324
+7,006
+3% +$197K
CMRX
60
DELISTED
Chimerix, Inc.
CMRX
$6.24M 0.12%
+6,501,624
New +$6.24M
THRD
61
DELISTED
Third Harmonic Bio
THRD
$6.15M 0.12%
+961,863
New +$6.15M
CNTB
62
Connect Biopharma
CNTB
$111M
$5.73M 0.11%
6,991,003
UNCY icon
63
Unicycive Therapeutics
UNCY
$75.8M
$2.98M 0.06%
+347,069
New +$2.98M
NSTG
64
DELISTED
NanoString Technologies, Inc.
NSTG
$2.96M 0.06%
1,723,373
MGNX icon
65
MacroGenics
MGNX
$121M
$1.59M 0.03%
+342,000
New +$1.59M
NAMSW icon
66
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$64M
$633K 0.01%
333,333
DSGN icon
67
Design Therapeutics
DSGN
$339M
-2,971,231
Closed -$18.7M
DICE
68
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
-7,856,612
Closed -$365M